logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 17
  • 1
    Muellershausen, Florian, Dr
    Born in December 1972
    Individual (3 offsprings)
    Officer
    2025-07-02 ~ now
    OF - Director → CIF 0
  • 2
    Draetta, Francesco
    Born in December 1984
    Individual (1 offspring)
    Officer
    2022-06-30 ~ now
    OF - Director → CIF 0
  • 3
    Johnson, Emma
    Born in July 1996
    Individual (8 offsprings)
    Officer
    2025-07-02 ~ 2025-12-10
    OF - Director → CIF 0
  • 4
    Roach, Arthur
    Company Director born in December 1957
    Individual (5 offsprings)
    Officer
    2019-06-27 ~ 2025-07-02
    OF - Director → CIF 0
  • 5
    Kremers, Charlotte Johanna Pauline
    Born in May 1995
    Individual (1 offspring)
    Officer
    2025-08-22 ~ now
    OF - Director → CIF 0
  • 6
    Nessi, Claudio
    Born in December 1968
    Individual (1 offspring)
    Officer
    2022-06-30 ~ now
    OF - Director → CIF 0
  • 7
    Miller, Neil Derek, Dr
    Born in July 1970
    Individual (3 offsprings)
    Officer
    2018-04-05 ~ now
    OF - Director → CIF 0
    Dr Neil Derek Miller
    Born in July 1970
    Individual (3 offsprings)
    Person with significant control
    2018-04-05 ~ 2022-06-30
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 8
    Hawthorne, Grant
    Director born in July 1972
    Individual (28 offsprings)
    Officer
    2018-04-05 ~ 2019-06-27
    OF - Director → CIF 0
    Hawthorne, Grant
    Individual (28 offsprings)
    Officer
    2022-12-02 ~ now
    OF - Secretary → CIF 0
    Mr Grant Hawthorne
    Born in July 1972
    Individual (28 offsprings)
    Person with significant control
    2018-04-05 ~ 2022-06-30
    PE - Right to appoint or remove directors → CIF 0
  • 9
    Seabrook, Richard Nicholas, Dr
    Strategic Adviser born in March 1959
    Individual (7 offsprings)
    Officer
    2019-11-05 ~ 2022-06-30
    OF - Director → CIF 0
  • 10
    Frost, Georgia Rose
    Born in March 1991
    Individual (1 offspring)
    Officer
    2026-02-02 ~ now
    OF - Director → CIF 0
  • 11
    Barker, Laurence Daniel Paul
    Born in July 1972
    Individual (8 offsprings)
    Officer
    2025-07-02 ~ 2026-02-02
    OF - Director → CIF 0
  • 12
    Tobin, Jonathan Leslie
    Venture Capitalist born in December 1982
    Individual (13 offsprings)
    Officer
    2022-06-30 ~ 2023-10-19
    OF - Director → CIF 0
  • 13
    Jackman, Katherine
    Investment Manager born in August 1981
    Individual (1 offspring)
    Officer
    2023-10-19 ~ 2025-07-02
    OF - Director → CIF 0
  • 14
    Savidge, Jonathan Rex, Dr
    Born in October 1973
    Individual (4 offsprings)
    Officer
    2023-04-06 ~ now
    OF - Director → CIF 0
  • 15
    Rutter, Anthony Richard, Dr
    Director born in March 1975
    Individual (4 offsprings)
    Officer
    2018-04-05 ~ 2019-06-27
    OF - Director → CIF 0
    Dr Anthony Richard Rutter
    Born in March 1975
    Individual (4 offsprings)
    Person with significant control
    2018-04-05 ~ 2022-06-30
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 16
    PARKINSON'S RESEARCH VENTURES LIMITED
    11228595
    215, Vauxhall Bridge Road, London, United Kingdom
    Active Corporate (26 parents, 2 offsprings)
    Person with significant control
    2022-07-07 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    2019-06-26 ~ 2022-07-01
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 17
    215, Vauxhall Bridge Road, London, England
    Corporate (1 offspring)
    Person with significant control
    2019-06-27 ~ 2019-06-27
    PE - Has significant influence or control → CIF 0
parent relation
Company in focus

NRG THERAPEUTICS LTD

Period: 2018-04-05 ~ now
Company number: 11294505
Registered name
NRG THERAPEUTICS LTD - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
72024-05-01 ~ 2025-04-30
62023-05-01 ~ 2024-04-30
Property, Plant & Equipment
4,812 GBP2025-04-30
7,842 GBP2024-04-30
Fixed Assets
4,812 GBP2025-04-30
7,842 GBP2024-04-30
Debtors
906,169 GBP2025-04-30
1,443,284 GBP2024-04-30
Cash at bank and in hand
3,557,769 GBP2025-04-30
5,252,323 GBP2024-04-30
Current Assets
4,463,938 GBP2025-04-30
6,695,607 GBP2024-04-30
Net Current Assets/Liabilities
2,271,105 GBP2025-04-30
4,900,775 GBP2024-04-30
Total Assets Less Current Liabilities
2,275,917 GBP2025-04-30
4,908,617 GBP2024-04-30
Net Assets/Liabilities
2,275,917 GBP2025-04-30
4,908,617 GBP2024-04-30
Equity
Called up share capital
5,340 GBP2025-04-30
4,534 GBP2024-04-30
4,534 GBP2023-05-01
Share premium
21,613,805 GBP2025-04-30
17,614,607 GBP2024-04-30
17,614,607 GBP2023-05-01
Retained earnings (accumulated losses)
-19,343,228 GBP2025-04-30
-12,710,524 GBP2024-04-30
-5,287,841 GBP2023-05-01
Equity
2,275,917 GBP2025-04-30
4,908,617 GBP2024-04-30
12,331,300 GBP2023-05-01
Profit/Loss
Retained earnings (accumulated losses)
-6,632,704 GBP2024-05-01 ~ 2025-04-30
-7,422,683 GBP2023-05-01 ~ 2024-04-30
Profit/Loss
-6,632,704 GBP2024-05-01 ~ 2025-04-30
-7,422,683 GBP2023-05-01 ~ 2024-04-30
Issue of Equity Instruments
Called up share capital
806 GBP2024-05-01 ~ 2025-04-30
Issue of Equity Instruments
4,000,004 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment - Gross Cost
Computers
18,216 GBP2025-04-30
15,608 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
13,404 GBP2025-04-30
7,766 GBP2024-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
5,638 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment
Computers
4,812 GBP2025-04-30
7,842 GBP2024-04-30
Other Debtors
Non-current
6,068 GBP2025-04-30
19,619 GBP2024-04-30
Debtors
Non-current
6,068 GBP2025-04-30
19,619 GBP2024-04-30
Other Debtors
Current
790,123 GBP2025-04-30
1,088,163 GBP2024-04-30
Prepayments/Accrued Income
Current
109,978 GBP2025-04-30
335,502 GBP2024-04-30
Debtors
Current
906,169 GBP2025-04-30
1,443,284 GBP2024-04-30
Trade Creditors/Trade Payables
Current
723,942 GBP2025-04-30
990,138 GBP2024-04-30
Taxation/Social Security Payable
Current
30,164 GBP2025-04-30
34,821 GBP2024-04-30
Other Creditors
Current
283 GBP2025-04-30
501,686 GBP2024-04-30
Accrued Liabilities/Deferred Income
Current
1,438,444 GBP2025-04-30
268,187 GBP2024-04-30
Creditors
Current
2,192,833 GBP2025-04-30
1,794,832 GBP2024-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
900,000 shares2025-04-30
900,000 shares2024-04-30
Par Value of Share
Class 1 ordinary share
0.0012024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
407,925 shares2025-04-30
407,925 shares2024-04-30
Par Value of Share
Class 2 ordinary share
0.0012024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
4,032,257 shares2025-04-30
3,225,807 shares2024-04-30
Par Value of Share
Class 3 ordinary share
0.0012024-05-01 ~ 2025-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
10,503 GBP2025-04-30
5,335 GBP2024-04-30
Between one and five year
4,376 GBP2025-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
14,879 GBP2025-04-30
5,335 GBP2024-04-30
  • NRG THERAPEUTICS LTD
    Info
    Registered number 11294505
    Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX
    PRIVATE LIMITED COMPANY incorporated on 2018-04-05 (8 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-04-04
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.